Yongfei Chen
Anhui University(CN)Sun Yat-sen University(CN)Hefei University of Technology(CN)Chinese Academy of Sciences(CN)Hefei Institutes of Physical Science(CN)Hangzhou Vocational and Technical College(CN)The First Affiliated Hospital, Sun Yat-sen University(CN)Precision Research (United States)(US)
Publications by Year
Research Areas
Retinoids in leukemia and cellular processes, Market Dynamics and Volatility, Acute Myeloid Leukemia Research, Energy, Environment, Economic Growth, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Synthesis and antifungal activity of 1,2,3-triazole phenylhydrazone derivatives(2014)122 cited
- → Synthesis of 1,2,3-triazole hydrazide derivatives exhibiting anti-phytopathogenic activity(2016)91 cited
- → Discovery of a Potent, Covalent BTK Inhibitor for B-Cell Lymphoma(2014)75 cited
- → Diastereo- and Enantioselective Aza-MBH-Type Reaction of Nitroalkenes to N-Tosylimines Catalyzed by Bifunctional Organocatalysts(2009)62 cited
- → A ROS‐Responsive Lipid Nanoparticles Release Multifunctional Hydrogel Based on Microenvironment Regulation Promotes Infected Diabetic Wound Healing(2024)62 cited
- → Discovery of N -(5-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl)phenyl)acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC